Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pulmonary Embolism (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableUnknownNCT04124159
What this trial is testing

Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism

Who this might be right for
Recurrent Venous Thrombosis
Medical University of Vienna 200
Large-scale testing (Phase 3)Study completedNCT00558259
What this trial is testing

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,353
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableUnknownNCT00261014
What this trial is testing

Understanding Risk Factors Involved in Developing a Second Blood Clot.

Who this might be right for
Deep Vein Thrombosis
Ottawa Hospital Research Institute 800
Post-approval studies (Phase 4)Study completedNCT00264277
What this trial is testing

D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 600
Large-scale testing (Phase 3)Ended earlyNCT05171049
What this trial is testing

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 1,150
Large-scale testing (Phase 3)Study completedNCT05515120
What this trial is testing

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Who this might be right for
Venous ThromboembolismAnticoagulant-induced BleedingVenous Thromboses+1 more
Instituto Mexicano del Seguro Social 58
Not applicableStudy completedNCT00720915
What this trial is testing

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
McMaster University 410
Not applicableLooking for participantsNCT06372730
What this trial is testing

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)

Who this might be right for
Pulmonary EmbolismVenous Thromboembolism
University Hospital, Brest 665
Large-scale testing (Phase 3)Study completedNCT01285661
What this trial is testing

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

Who this might be right for
Deep Vein Thrombosis of Lower LimbLower Extremity Deep Venous Thrombosis Recurrent
University of Padova 584
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Not applicableStudy completedNCT02884934
What this trial is testing

Six Years of Follow-up After Idiopathic Venous Throbmoembolism

Who this might be right for
Pulmonary EmbolismProximal Deep Vein Thrombosis
University Hospital, Brest 409
Not applicableWithdrawnNCT03812835
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Who this might be right for
Thrombosis, Deep VeinPulmonary Embolism
Pfizer
Large-scale testing (Phase 3)Study completedNCT02064439
What this trial is testing

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Who this might be right for
Pulmonary EmbolismThromboembolismThrombosis+2 more
Bayer 3,365
Large-scale testing (Phase 3)WithdrawnNCT01164540
What this trial is testing

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

Who this might be right for
Venous ThrombosisPulmonary Embolism
AstraZeneca 3,000
Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600
Large-scale testing (Phase 3)Ended earlyNCT01164046
What this trial is testing

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

Who this might be right for
Venous ThromboembolismNeoplasms
University Medical Center Groningen 56
Post-approval studies (Phase 4)UnknownNCT02979561
What this trial is testing

Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy

Who this might be right for
Angiographically Confirmed Acute Massive Pulmonary Embolism Treated With Endovascular Mechanical Fragmentation and Thrombolytic Therapy
Meshalkin Research Institute of Pathology of Circulation 200
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70